Appelt PA, Comella K, de Souza LAPS, Luvizutto GJ. Effect of stem cell treatment on functional recovery of spinocerebellar ataxia: systematic review and meta-analysis. Cerebellum Ataxias. 2021 Feb 25;8(1):8. doi: 10.1186/s40673-021-00130-8. PmiD: 33632326; PMCID: PMC7905903.
Sabino Pinho de Oliveira B, Putti S, Naro F, Pellegrini M. Bone Marrow Transplantation as Therapy for Ataxia-Telangiectasia: A Systematic Review. Cancers. 2020; 12(11):3207.
Tsai YA, Liu RS, Lirng JF, Yang BH, Chang CH, Wang YC, Wu YS, Ho JH, Lee OK, Soong BW. Treatment of spinocerebellar ataxia with mesenchymal stem cells: a phase I/IIa clinical study. Cell transplantation. 2017 Mar;26(3):503-12.
Jin JL, Liu Z, Lu ZJ, Guan DN, Wang C, Chen ZB, Zhang J, Zhang WY, Wu JY, Xu Y. Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Current neurovascular research. 2013 Feb 1;10(1):11-20.
Dongmei H, Jing L, Mei X, Ling Z, Hongmin Y, Zhidong W, Li D, Zikuan G, Hengxiang W. Clinical analysis of the treatment of spinocerebellar ataxia and multiple system atrophy-cerebellar type with umbilical cord mesenchymal stromal cells. Cytotherapy. 2011 Sep 1;13(8):913-7.
Riza Azeri, Duygu Koyuncu Irmak, Eda Sun, & Erdal Karaöz. Safety and Efficacy of The Stem Cell Transplantation in Friedreich’s Ataxia: A Report of Three Cases. International Journal of Physiotherapy, 2021;8(1):31-35.
Ko PW, Park S, Kang K, Lim YH, Kim SR, Suk K, Kim KS, Lee HW. Human Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Cerebellar Ataxia: A Case Report. Medicina (Kaunas). 2021 Apr 1;57(4):334. doi: 10.3390/medicina57040334. PmiD: 33915966; PMCID: PMC8067136.
Mehri A, Toosi MB, Tavasoli AR, Saberi-Karimian M. The latest developments for the treatment of ataxia telangiectasia: a narrative review. The Cerebellum. 2024;23(6):2607-2615.
Lee GB, Park SM, Jung UJ, Kim SR. The Potential of Mesenchymal Stem Cells in Treating Spinocerebellar Ataxia: Advances and Future Directions. Biomedicines. 2024;12(11):2507.
Louit A, Beaudet MJ, Blais M, Gros-Louis F, Dupré N, Berthod F. In Vitro Characterization of Motor Neurons and Purkinje Cells Differentiated From Induced Pluripotent Stem Cells Generated From Patients With Autosomal Recessive Spastic Ataxia of Charlevoix‐Saguenay. Stem Cells International. 2023;2023(1):1496597.
Dionisi C, Chazalon M, Rai M, Keime C, Imbault V, Communi D, Pandolfo M. Proprioceptors-enriched neuronal cultures from induced pluripotent stem cells from Friedreich ataxia patients show altered transcriptomic and proteomic profiles, abnormal neurite extension, and impaired electrophysiological properties. Brain Communications. 2023;5(1):fcad007.
Nurieva W, Ivanova E, Chehab S, Singh P, Reichlmeir M, Szuhai K, Ivics Z. Generation of four gene-edited human induced pluripotent stem cell lines with mutations in the ATM gene to model Ataxia-Telangiectasia. Stem Cell Research. 2023;73:103247.
Maheshwari S, Vilema-Enríquez G, Wade-Martins R. Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application. Translational Neurodegeneration. 2023;12(1):45.
